Dynamics of soluble vascular endothelial growth factor receptors and their ligands in aqueous humour during ranibizumab for age-related macular degeneration
Abstract Background Intravitreal ranibizumab injection (IRI) is effective for patients with exudative age-related macular degeneration (AMD) and decreases intraocular levels of vascular endothelial growth factor (VEGF), but VEGF receptor intraocular dynamics after IRI are unclear. Therefore, we eval...
Saved in:
Main Authors: | Ryosuke Motohashi (Author), Hidetaka Noma (Author), Kanako Yasuda (Author), Osamu Kotake (Author), Hiroshi Goto (Author), Masahiko Shimura (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
by: Asako Mashima, et al.
Published: (2019) -
Effect of conbercept or ranibizumab in the treatment of wet age-related macular degeneration
by: Dawei Zhang, et al.
Published: (2019) -
Profile of ranibizumab: efficacy and safety for the treatment of wet age-related macular degeneration
by: Chen Y, et al.
Published: (2012) -
Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis
by: Wang LP, et al.
Published: (2018) -
Effect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration
by: Panos GD, et al.
Published: (2013)